Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi

Abstract

BackgroundSubstandard and falsified anti-malarial medicines pose a serious threat to public health, especially in low-income countries. Appropriate technologies for drug quality analysis in resource-limited settings are important for the surveillance of the formal and informal drug market. The feasibility of thin-layer chromatography (TLC) with different solvent systems was tested using the GPHF Minilab in a study of the quality of sulfadoxine/pyrimethamine tablets in Malawi.MethodsTwenty eight samples of sulfadoxine/pyrimethamine tablets were collected from randomly selected health facilities of four districts of southern Malawi. A mystery shopper approach was used when collecting samples from illegal street vendors, and an overt approach for the other facilities. Samples were subjected to visual inspection, disintegration testing and TLC analysis. 10 samples were further investigated according to the methods of the US Pharmacopeia using high performance liquid chromatography (HPLC).ResultsOne sample was found to be falsified, containing a mixture of paracetamol tablets and co-trimoxazole tablets. These had been repackaged into paper strip packs labelled as a brand of sulfadoxine/pyrimethamine. TLC with different solvent systems readily proved that these tablets did not comply with their declaration, and provided strong evidence for the active pharmaceutical ingredients which were actually contained. Full pharmacopeial analysis by HPLC confirmed the results suggested by TLC for this sample, and showed two further samples to be of substandard quality.ConclusionsDue to the absence of the declared anti-malarial ingredients and due to the presence of other pharmaceutical ingredients, the identified falsified medicine represents a serious health risk for the population. Thin-layer chromatography (TLC) using different solvent systems proved to be a powerful method for the identification of this type of counterfeiting, presenting a simple and affordable technology for use in resource-limited settings.

A systematic review of the use of simulated patient methodology in pharmacy practice research from 2006 to 2016

“…Out of the 1107 papers in the original search and two added due to quoting the 2006 review, 148 papers met the criteria . Extraction of relevant papers from those found by the search strategy was done jointly by two researchers (IB and PN) and independently by a third researcher (AA).…”

“…Other studies investigated whether prescription drugs legislation was violated . Simulated patients were used in developing countries to assess whether the medicines sold were substandard . This combination of pharmacy practice and pharmaceutical analytical research methods to map quality of products reflects a new use for the SP methodology, which has a great deal of potential.…”

Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi

“…= not applicable.*Sold by a nonlicensed street vendor, with no indication of product name, manufacturer, and expiry date.†Labeled as a medicine from a Malawian manufacturer 24…”

Quality of the antimalarial medicine artemether – lumefantrine in 8 cities of the Democratic Republic of the Congo

“…It is cost‐effective, simple, and rapid. In most of the studies conducted in Africa and Asia, the Global Pharma Health Fund (GPHF) Minilab protocols were used as a semi‐quantitative assessment tool . During the pilot study conducted only in Kinshasa (Supporting Information) with a very limited number of samples, the results obtained from the Minilab® kit were similar to those obtained using the assay method of The International Pharmacopoeia TLC monograph for identity control of APIs.…”